Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical announced a definitive merger agreement to merge its wholly owned subsidiary Cortigent, Inc. with ClearOne, Inc. Under the transaction, Cortigent will become a wholly owned subsidiary of ClearOne, which will be renamed Cortigent Holdings, Inc. and trade under ticker symbol 'CRGT'. ClearOne will raise $10-15 million in concurrent financing. Vivani will receive 12.5 million shares and own 59.4-67.5% of the combined company. The transaction is expected to close in Q3 2026.